MTHFR and hyperhomocysteinemia: This phase also saw the discovery of MTHFR C677T polymorphism by Frosst et al. [16], which highlighted a genetic determinant of mild hyperhomocysteinemia, particularly in low-folate settings, and cemented the hypothesis of a genetic–biochemical disease axis.